Anzeige
Mehr »
Login
Freitag, 31.01.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Gold-Rally Richtung 3.000 $: Der brasilianische Gold-Play, das Sie kennen sollten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10.01.IGM, Y-mAbs, Passage Bio and more telegraph staff cuts amid restructuring spree
10.01.4DMT tosses 2 programs, halts funds for 3 others as it zeroes in on latest-stage clinical gene therapy
10.01.Kardigan launches with cozy $300M series A and collection of late-stage cardio assets
10.01.Saluda Medical toasts $100M fundraising to pep up sales of its closed-loop neurostimulator
10.01.AbbVie takes $3.5B hit after emraclidine's phase 2 flop in schizophrenia
10.01.Eli Lilly, Andreessen Horowitz link up on $500M biotech venture fund
10.01.Novo Holdings-backed Windward generates $200M series A, inks $970M biobucks deal for clinical antibody
10.01.Biotech creator and China's Keymed launch antibody company with $180M series A
10.01.Eli Lilly pushes into pulmonary fibrosis with $99M deal for Mediar's midphase prospect
10.01.Pfizer's PD-1 prospect beats age-old incumbent in phase 3 bladder cancer trial
10.01.Bausch + Lomb pens $485M-plus biobucks pact with City Tx for RNAi eye disease work
10.01.Repare cans plans for phase 3 cancer combo trial in latest money-saving move
10.01.Intellia, citing 'challenging market environment,' lays off 27% of staff as it takes ax to pipeline
08.01.Sana's cell therapy may be 'transformative cure' for type 1 diabetes: analysts
08.01.Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes
08.01.LB Pharma's twist on old Sanofi drug passes schizophrenia test, teeing up phase 3 push
08.01.Galapagos splits in two, laying off 40% of staff, shrinking pipeline and ending Gilead partnership
08.01.Sanofi inks $400M biobucks deal to test the mettle of Alloy's antisense platform
08.01.Cassava lays off 3rd of workforce in wake of phase 3 Alzheimer's fail
07.01.Global CRO QPS makes Ryght choice for AI to automate clinical trials
07.01.FIRE1 heats up with $120M for its heart failure monitor implant
07.01.Stryker inks $4.9B deal for blood clot buster Inari Medical
07.01.AbbVie exercises first $40 million option to advance Capsida-partnered CNS gene therapy
07.01.Novo Nordisk and Variant set out to find new metabolic treatments, pay communities that share genetic data
07.01.Aviceda raises $207M series C to take geographic atrophy drug through phase 3